Molecular Gastroenterology and Hepatology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Division of Research and Development for Minimally Invasive Treatment, Cancer Center, Keio University School of Medicine, Tokyo, Japan.
Dig Endosc. 2023 Nov;35(7):879-888. doi: 10.1111/den.14552. Epub 2023 Apr 23.
This study aimed to elucidate the clinical course and management of adverse events (AEs) after endoscopic resection (ER) for superficial duodenal epithelial tumors (SDETs).
Consecutive patients who underwent ER of SDETs between January 2008 and July 2018 at 18 Japanese institutions were retrospectively enrolled. The study outcomes included the clinical course, management, and risk of surgical conversion with perioperative AEs after ER for SDETs.
Of the 226 patients with AEs, the surgical conversion rate was 8.0% (18/226), including 3.7% (4/108), 1.0% (1/99), and 50.0% (12/24) of patients with intraoperative perforation, delayed bleeding, or delayed perforation, respectively. In the multivariate logistic analysis, involvement of the major papilla (odds ratio [OR] 12.788; 95% confidence interval [CI] 2.098-77.961, P = 0.006) and delayed perforation (OR 37.054; 95% CI 10.219-134.366, P < 0.001) were significant risk factors for surgical conversion after AEs. Delayed bleeding occurred from postoperative days 1-14 or more, whereas delayed perforation occurred within 3 days in all cases.
The surgical conversion rate was higher for delayed perforation than those for other AEs after ER of SDETs. Involvement of the major papilla and delayed perforation were significant risk factors for surgical conversion following AEs. In addition, reliable prevention of delayed perforation is required for 3 days after duodenal ER to prevent the need for surgical interventions.
本研究旨在阐明内镜下切除(ER)治疗浅层十二指肠上皮肿瘤(SDET)后不良事件(AE)的临床过程和管理。
回顾性纳入 2008 年 1 月至 2018 年 7 月期间在 18 家日本机构接受 ER 治疗的 SDET 连续患者。本研究的结果包括 ER 治疗 SDET 后 AE 的临床过程、管理以及与围手术期 AE 相关的手术转换风险。
在 226 例 AE 患者中,手术转化率为 8.0%(18/226),其中术中穿孔、延迟性出血和延迟性穿孔分别占 3.7%(4/108)、1.0%(1/99)和 50.0%(12/24)。多变量逻辑分析显示,主要乳头受累(优势比[OR]12.788;95%置信区间[CI]2.098-77.961,P=0.006)和延迟性穿孔(OR 37.054;95%CI 10.219-134.366,P<0.001)是 AE 后手术转换的显著危险因素。延迟性出血发生在术后 1-14 天或更长时间,而所有延迟性穿孔均发生在术后 3 天内。
ER 治疗 SDET 后,延迟性穿孔的手术转化率高于其他 AE。主要乳头受累和延迟性穿孔是 AE 后手术转换的显著危险因素。此外,为防止需要手术干预,ER 后 3 天内需要可靠地预防延迟性穿孔。